Nervecept® formula & order desk · Cycle 2026 · U.S. stock · Payment runs on the maker's BuyGoods checkout
Order Now • From $49
IngredientsHow It WorksSupplement FactsPricingReviewsFAQClinical BlogOrder Nervecept • From $49
Comparison

Alpha-Lipoic Acid for Neuropathy: Doses, Trials and Cautions

Alpha-lipoic acid is the supplement with the most neuropathy-specific trial data. Nervecept does not contain it, which is worth understanding before you buy either.

Updated October 16, 2026Matched to the bottle label5 cited sources

What alpha-lipoic acid is

Alpha-lipoic acid (ALA) is a sulfur-containing compound the body makes in small amounts and uses in energy metabolism. It is also an antioxidant. Oxidative stress is one of the proposed mechanisms of nerve damage in diabetes, which is why ALA has been studied for diabetic neuropathy.

The trials

A meta-analysis of four trials, mostly of intravenous ALA at 600 mg a day for three weeks, found reduced neuropathic symptom scores[1]. The SYDNEY 2 trial tested oral doses of 600, 1,200 and 1,800 mg for five weeks and found symptom improvements at all doses, with more side effects at higher doses[2]. These were short trials; long-term effects on nerve damage remain uncertain.

Cautions

  • ALA may lower blood sugar; people on diabetes medicines should monitor closely and involve their care team.
  • Nausea is the most common side effect, more so at higher doses.
  • It does not replace glucose control, which remains the foundation of diabetic neuropathy care[3][4].

Forms, timing and what to discuss

Supplements sell ALA as the standard mix of two mirror-image forms or as the R form alone. Most of the trial evidence used the standard form at 600 mg once a day. Food appears to reduce absorption, so it is commonly taken before breakfast. Because ALA may lower blood glucose, people on insulin or sulfonylureas should only start it with their diabetes team involved and should monitor more often for the first weeks. It is a reasonable topic to raise at an appointment; it is not a substitute for glucose control or prescribed treatment.

ALA versus Nervecept

ALA is a single ingredient studied directly for neuropathy symptoms. Nervecept is a multi-ingredient joint-type formula without ALA. They are not substitutes, and taking both should be discussed with a clinician. As always, tell every clinician which supplements you take[5].

Sources for this page

Each entry links to the original record. These studies test single ingredients, usually at higher doses; none tested the finished Nervecept capsule.

  1. 1Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004;21(2):114-121. pubmed.ncbi.nlm.nih.gov/14984445/
  2. 2Ziegler D, Ametov A, Barinov A, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006;29(11):2365-2370. pubmed.ncbi.nlm.nih.gov/17065669/
  3. 3Pop-Busui R, Boulton AJ, Feldman EL, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154. pubmed.ncbi.nlm.nih.gov/27999003/
  4. 4Feldman EL, Callaghan BC, Pop-Busui R, et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;5(1):41. pubmed.ncbi.nlm.nih.gov/31197153/
  5. 5National Center for Complementary and Integrative Health. Using Dietary Supplements Wisely. www.nccih.nih.gov/health/using-dietary-supplements-wisely

Ready to give Nervecept a fair 60 days?

Orders complete on the maker's BuyGoods checkout. The refund policy covers opened and empty bottles if you email support within the 60-day window.

Order Nervecept · from $49Compare bottle packs